THORAFLEX HYBRID
Live / Registered — Registered — international registration renewed (as of 03 Sept 2023)
What this means for you
Registered since 05 Dec 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79198477
- Registration number
- 5348216
- Mark type
- Stylized text
- Filed
- 07 Sept 2016
- Published for opposition
- 19 Sept 2017
- Registered
- 05 Dec 2017
- Attorney of record
- Megan E. Fink
Goods and services
- Class 010 — Medical apparatus: Surgical apparatus and instruments for medical [, dental and veterinary ] use; [ synthetic bone grafts, stents, drug delivery patches sold without medication and bone prostheses; ] surgical implants comprised of artificial materials; [ suture materials, namely, patches for repair and reconstruction of internal tissue; ] implantable medical systems comprised of synthetic endovascular stent grafts; [ implantable medical devices, namely, synthetic endovascular stent grafts; ] artificial vascular grafts; [ artificial endovascular grafts; surgical graft materials, namely, artificial endovascular grafts, artificial endovascular grafts; medical systems, namely, system for use in artificial organ support; medical devices for measuring blood sugar for medical purposes; ] medical apparatus and instruments for use in endovascular procedures; [ medical thoracic stents; ] synthetic thoracic stent grafts; synthetic stent grafts; synthetic stent graft systems comprised of medical stent grafts and stent delivery systems; stent graft devices comprised of medical stent grafts and stent delivery systems; stent graft systems and devices comprising more than one component, namely, artificial endovascular grafts; stent graft systems and devices comprising components of more than one stent graft, namely, artificial endovascular grafts; stent graft systems and devices comprising components of more than one type of stent graft, namely, artificial endovascular grafts [, stent delivery systems and synthetic stent grafts ] ; thoracic stent graft systems, namely, artificial endovascular grafts stent delivery systems and synthetic stent grafts; [ thoracic stent graft devices, namely, artificial endovascular grafts, stent delivery systems and synthetic stent grafts; ] delivery systems for stent graft systems and stent graft devices; [ medical devices, namely, minimally invasive devices for abdominal aortic aneurysms repair; cardiac valves for surgical prostheses; cardiac valve replacement systems comprised of artificial cardiac heart valves; medical apparatus for treating congestive heart failure, namely, heart valve conduits; cardiac drug patches sold without medication; vascular drug patches sold without medication; structural parts and fittings for all of the aforementioned goods ] and all the foregoing excluding prostheses used for shoulder surgery, shoulder replacements, or medical treatment for the shoulder
Owner
- Vascutek Limited, Renfrewshire, GB
- Vascutek Limited, GB
- Vascutek Limited, GB
Prosecution history
- 20 Mar 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Mar 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 20 Mar 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Apr 2024 — INTERNATIONAL REGISTRATION RENEWED
- 03 Sept 2023 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 03 Sept 2023 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 03 Sept 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 15 Feb 2023 — TEAS SECTION 71 & 15 RECEIVED
- 05 Dec 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 11 May 2018 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 20 Mar 2018 — FINAL DISPOSITION NOTICE SENT TO IB
- 20 Mar 2018 — FINAL DISPOSITION PROCESSED
- 05 Mar 2018 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB